4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001209191-24-000780
Chief Operating Officer sold 3,000 shares at an average $63.91 ($191,741)
- Chief Operating Officer acquired 3,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wassil Jim Chief Operating Officer | 2024-01-02 | Option exercise 10b5-1 | +3,000 | $2.42 | $7,260 | 178,935 | D |
| Wassil Jim Chief Operating Officer | 2024-01-02 | Sale 10b5-1 | −289 | $62.71 | $18,123 | 178,646 | D |
| Wassil Jim Chief Operating Officer | 2024-01-02 | Sale 10b5-1 | −1,039 | $63.55 | $66,025 | 177,607 | D |
| Wassil Jim Chief Operating Officer | 2024-01-02 | Sale 10b5-1 | −1,562 | $64.29 | $100,426 | 176,045 | D |
| Wassil Jim Chief Operating Officer | 2024-01-02 | Sale 10b5-1 | −110 | $65.15 | $7,167 | 175,935 | D |
| Derivatives | |||||||
| Wassil Jim Chief Operating Officer | 2024-01-02 | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 93,555 | D | ||
| Open-market sales · 3,000 sh · avg $63.91 · $191,741 | |||||||
Loading xslF345X05/doc4.xml…